Skip to main content
Top
Published in: Journal of General Internal Medicine 7/2021

01-07-2021 | Original Research

The Role of Physician Professional Networks in Physicians’ Receipt of Pharmaceutical and Medical Device Industries’ Payments

Authors: Aaron N. Winn, PhD, MPP, Aaron P. Mitchell, MD, MPH, Nicole Fergestrom, MS, Joan M. Neuner, MD, MPH, Justin G. Trogdon, PhD

Published in: Journal of General Internal Medicine | Issue 7/2021

Login to get access

Abstract

Background

Financial relationships between physicians and the pharmaceutical and medical device industries are common, but the factors associated with physicians receiving payments are unknown.

Objective

The objective of this study is to evaluate the influence of physicians’ professional networks’ characteristics on the receipt of payments among physicians.

Design

Network analysis of cross-sectional data

Participants

US physicians who shared Medicare patients with other physicians in 2015 (N=357,813).

Exposure (Intervention)

Proportion of a physician’s professional network that received industry payments and other network characteristics including number of physician connections, how central the physician is within the network, and the tightness of the referral network in which a physician is located.

Main Outcome Measures

Relative risk of receiving industry payments. We used modified Poisson regression to control for confounding by gender, time since graduation, practice size, and practice setting (teaching hospital vs. not). We included dummy variables for specialty and hospital referral region level.

Key Results

The proportion of a physician’s peers in their professional network that received payments was strongly associated with receipt of pharmaceutical or device industry payments by the physician (top vs bottom quartile aRR=1.28, 95%CI=1.25–1.31). Physician’s centrality within a network had a small positive effect on receiving payment (top vs bottom quartile aRR=1.02, 95%CI=1.01–1.04). Network density also had a small negative association with receipt of payment (top vs bottom quartile aRR=0.97, 95%CI=0.96–0.98).

Conclusions

Network characteristics, particularly the receipt of payments among physicians one shares patients with, are associated with whether a physician receives payments. This finding has implications for institutional regulation of industry payments to physicians and demonstrates how institutional policy may impact not only the physicians within the institution but also physicians outside of the institution.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lo B, Field MJ (eds) Conflict of Interest in Medical Research, Education, and Practice. Washington (DC); 2009. Lo B, Field MJ (eds) Conflict of Interest in Medical Research, Education, and Practice. Washington (DC); 2009.
2.
go back to reference Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ. Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med. 2006;355(22):2330-2337.CrossRef Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ. Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med. 2006;355(22):2330-2337.CrossRef
3.
go back to reference Rose SL, Sah S, Dweik R, Schmidt C, Mercer M, Mitchum A, et al. Patient responses to physician disclosures of industry conflicts of interest: A randomized field experiment. Organ Behav Hum Decis Process. 2019. Rose SL, Sah S, Dweik R, Schmidt C, Mercer M, Mitchum A, et al. Patient responses to physician disclosures of industry conflicts of interest: A randomized field experiment. Organ Behav Hum Decis Process. 2019.
4.
go back to reference Lerner TG, Miranda Mda C, Lera AT, Ueda A, Briones B, Del Giglio A, et al. The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials. Contemp Clin Trials. 2012;33(5):1019-1022.CrossRef Lerner TG, Miranda Mda C, Lera AT, Ueda A, Briones B, Del Giglio A, et al. The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials. Contemp Clin Trials. 2012;33(5):1019-1022.CrossRef
5.
go back to reference Tibau A, Bedard PL, Srikanthan A, Ethier JL, Vera-Badillo FE, Templeton AJ, et al. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs. J Clin Oncol 2015;33(1):100-106.CrossRef Tibau A, Bedard PL, Srikanthan A, Ethier JL, Vera-Badillo FE, Templeton AJ, et al. Author financial conflicts of interest, industry funding, and clinical practice guidelines for anticancer drugs. J Clin Oncol 2015;33(1):100-106.CrossRef
6.
go back to reference Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283(3):373-380.CrossRef Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283(3):373-380.CrossRef
7.
go back to reference Lieb K, Scheurich A. Contact between doctors and the pharmaceutical industry, their perceptions, and the effects on prescribing habits. PLoS One. 2014;9(10):e110130.CrossRef Lieb K, Scheurich A. Contact between doctors and the pharmaceutical industry, their perceptions, and the effects on prescribing habits. PLoS One. 2014;9(10):e110130.CrossRef
8.
go back to reference Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med. 2010;7(10):e1000352.CrossRef Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med. 2010;7(10):e1000352.CrossRef
9.
go back to reference DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. JAMA Intern Med. 2016;176(8):1114-1122.CrossRef DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. JAMA Intern Med. 2016;176(8):1114-1122.CrossRef
10.
go back to reference Perlis RH, Perlis CS. Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs. PLoS One. 2016;11(5):e0155474.CrossRef Perlis RH, Perlis CS. Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs. PLoS One. 2016;11(5):e0155474.CrossRef
11.
go back to reference Mitchell AP, Winn AN, Dusetzina SB. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries. JAMA Intern Med. 2018;178(6):854-856.CrossRef Mitchell AP, Winn AN, Dusetzina SB. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries. JAMA Intern Med. 2018;178(6):854-856.CrossRef
13.
go back to reference Inoue K, Blumenthal DM, Elashoff D, Tsugawa Y. Association between physician characteristics and payments from industry in 2015-2017: observational study. BMJ Open. 2019;9(9):e031010.CrossRef Inoue K, Blumenthal DM, Elashoff D, Tsugawa Y. Association between physician characteristics and payments from industry in 2015-2017: observational study. BMJ Open. 2019;9(9):e031010.CrossRef
14.
go back to reference Tringale KR, Hattangadi-Gluth JA. Types and Distributions of Biomedical Industry Payments to Men and Women Physicians by Specialty, 2015. JAMA Intern Med. 2018;178(3):421-423.CrossRef Tringale KR, Hattangadi-Gluth JA. Types and Distributions of Biomedical Industry Payments to Men and Women Physicians by Specialty, 2015. JAMA Intern Med. 2018;178(3):421-423.CrossRef
15.
go back to reference Landon BE, Keating NL, Barnett ML, Onnela JP, Paul S, O'Malley AJ, et al. Variation in patient-sharing networks of physicians across the United States. JAMA. 2012;308(3):265-273.CrossRef Landon BE, Keating NL, Barnett ML, Onnela JP, Paul S, O'Malley AJ, et al. Variation in patient-sharing networks of physicians across the United States. JAMA. 2012;308(3):265-273.CrossRef
16.
go back to reference Barnett ML, Christakis NA, O'Malley J, Onnela JP, Keating NL, Landon BE. Physician patient-sharing networks and the cost and intensity of care in US hospitals. Med Care. 2012;50(2):152-160.CrossRef Barnett ML, Christakis NA, O'Malley J, Onnela JP, Keating NL, Landon BE. Physician patient-sharing networks and the cost and intensity of care in US hospitals. Med Care. 2012;50(2):152-160.CrossRef
17.
go back to reference Casalino LP, Pesko MF, Ryan AM, Nyweide DJ, Iwashyna TJ, Sun X, et al. Physician Networks and Ambulatory Care-sensitive Admissions. Med Care. 2015;53(6):534-541.CrossRef Casalino LP, Pesko MF, Ryan AM, Nyweide DJ, Iwashyna TJ, Sun X, et al. Physician Networks and Ambulatory Care-sensitive Admissions. Med Care. 2015;53(6):534-541.CrossRef
20.
go back to reference Wennberg J, Gittelsohn. Small area variations in health care delivery. Science. 1973;182(4117):1102-1108.CrossRef Wennberg J, Gittelsohn. Small area variations in health care delivery. Science. 1973;182(4117):1102-1108.CrossRef
21.
go back to reference Fisher ES. Dartmouth Atlas of Health Care- Hospital Referral Region. Lebanon, NH: Dartmouth Institute for Health Policy and Clinical Practice; 2019. Fisher ES. Dartmouth Atlas of Health Care- Hospital Referral Region. Lebanon, NH: Dartmouth Institute for Health Policy and Clinical Practice; 2019.
22.
go back to reference Freeman LC. Centrality in Social Networks conceptual clarification. Soc Netw. 1979;1(3):215-239.CrossRef Freeman LC. Centrality in Social Networks conceptual clarification. Soc Netw. 1979;1(3):215-239.CrossRef
23.
go back to reference Newman MEJ. The structure and function of complex networks. Siam Rev. 2003;45(2):167-256.CrossRef Newman MEJ. The structure and function of complex networks. Siam Rev. 2003;45(2):167-256.CrossRef
24.
go back to reference Goldsmith-Pinkham P, Imbens GW. Social Networks and the Identification of Peer Effects. J Bus Econ Stat. 2013;31(3):253-264.CrossRef Goldsmith-Pinkham P, Imbens GW. Social Networks and the Identification of Peer Effects. J Bus Econ Stat. 2013;31(3):253-264.CrossRef
25.
go back to reference Williams R. Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata J. 2012;12(2):308-331.CrossRef Williams R. Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata J. 2012;12(2):308-331.CrossRef
26.
go back to reference Manski CF. Identification of endogenous social effects: The reflection problem. Rev Econ Stud. 1993;60(3):531-542.CrossRef Manski CF. Identification of endogenous social effects: The reflection problem. Rev Econ Stud. 1993;60(3):531-542.CrossRef
27.
go back to reference Bramoulle Y, Djebbari H, Fortin B. Identification of peer effects through social networks. J Econ. 2009;150(1):41-55.CrossRef Bramoulle Y, Djebbari H, Fortin B. Identification of peer effects through social networks. J Econ. 2009;150(1):41-55.CrossRef
28.
go back to reference Ahn T, Trogdon JG. Peer delinquency and student achievement in middle school. Labour Econ. 2017;44:192-217.CrossRef Ahn T, Trogdon JG. Peer delinquency and student achievement in middle school. Labour Econ. 2017;44:192-217.CrossRef
29.
go back to reference Terza J, Basu A, Rathouz P. Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling. J Health Econ. 2008;27(3):12.CrossRef Terza J, Basu A, Rathouz P. Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling. J Health Econ. 2008;27(3):12.CrossRef
30.
go back to reference Mitchell AP, Lund JL, Winn AN, Dusetzina SB. Evaluating the Strength of the Association Between Industry Payments and Prescribing in Oncology. The Oncologist. 2019;Accepted. Mitchell AP, Lund JL, Winn AN, Dusetzina SB. Evaluating the Strength of the Association Between Industry Payments and Prescribing in Oncology. The Oncologist. 2019;Accepted.
31.
go back to reference Anderson TS, Good CB, Gellad WF. Industry Payments to Academic Physicians: a Comparison of Reporting to Two Government Agencies. J Gen Intern Med. 2018;33(10):1604-1606.CrossRef Anderson TS, Good CB, Gellad WF. Industry Payments to Academic Physicians: a Comparison of Reporting to Two Government Agencies. J Gen Intern Med. 2018;33(10):1604-1606.CrossRef
32.
go back to reference Onnela JP, O’Malley AJ, Keating NL, Landon BE. Comparison of physician networks constructed from thresholded ties versus shared clinical episodes. Appl Netw Sci. 2018;3(1):28.CrossRef Onnela JP, O’Malley AJ, Keating NL, Landon BE. Comparison of physician networks constructed from thresholded ties versus shared clinical episodes. Appl Netw Sci. 2018;3(1):28.CrossRef
33.
go back to reference Donohue JM, Guclu H, Gellad WF, Chang CH, Huskamp HA, Choudhry NK, et al. Influence of peer networks on physician adoption of new drugs. PLoS One. 2018;13(10):e0204826.CrossRef Donohue JM, Guclu H, Gellad WF, Chang CH, Huskamp HA, Choudhry NK, et al. Influence of peer networks on physician adoption of new drugs. PLoS One. 2018;13(10):e0204826.CrossRef
34.
go back to reference Barnett ML, Landon BE, O'Malley AJ, Keating NL, Christakis NA. Mapping physician networks with self-reported and administrative data. Health Serv Res. 2011;46(5):1592-1609.CrossRef Barnett ML, Landon BE, O'Malley AJ, Keating NL, Christakis NA. Mapping physician networks with self-reported and administrative data. Health Serv Res. 2011;46(5):1592-1609.CrossRef
Metadata
Title
The Role of Physician Professional Networks in Physicians’ Receipt of Pharmaceutical and Medical Device Industries’ Payments
Authors
Aaron N. Winn, PhD, MPP
Aaron P. Mitchell, MD, MPH
Nicole Fergestrom, MS
Joan M. Neuner, MD, MPH
Justin G. Trogdon, PhD
Publication date
01-07-2021
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 7/2021
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-021-06802-9

Other articles of this Issue 7/2021

Journal of General Internal Medicine 7/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine